Answers are grounded in this paper and cite their sources.
Orthopedic implants are susceptible to complications such as implant-associated infections and prosthesis loosening. Antibiotic-loaded poly(methyl methacrylate) (PMMA) bone cement is limited by short-term antibacterial activity and poor biological performance, restricting its potential for simultaneous infection management and bone repair. Herein, bacterial cellulose (BC) was incorporated into PMMA bone cement to improve its pore structure, drug release behavior, and biological properties. BC incorporation increased the total porosity from 4.79 to 24.9% and the proportion of open pores from 51.7 to 95.2%. Gentamicin sulfate (GS) release duration was extended from 1 to 4 weeks, while the cumulative release percentage increased from 9.44 to 33.97%. The sustained release of GS was accompanied by prolonged antibacterial activity against S. aureus. In addition, BC incorporation improved in vitro mineralization and supported cell adhesion and proliferation. In a rat calvarial defect model, the PMMA/BC composite exhibited greater new bone formation than PMMA, indicating improved bone repair performance. Collectively, these findings demonstrate the potential of PMMA/BC composite bone cement for sustained local antibiotic delivery and bone defect repair.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: